Cargando…
HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies
Gastric cancer is an aggressive disease with increasing global incidence in recent years. Human epidermal growth receptor 2 (HER2) is overexpressed in approximately 10–20% of gastric cancers. The implementation of targeted therapy against HER2 as part of the standard of care treatment in metastatic...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380453/ https://www.ncbi.nlm.nih.gov/pubmed/37511163 http://dx.doi.org/10.3390/ijms241411403 |